Kadimastem Revenue and Competitors
Estimated Revenue & Valuation
- Kadimastem's estimated annual revenue is currently $7.6M per year.
- Kadimastem's estimated revenue per employee is $155,000
Employee Data
- Kadimastem has 49 Employees.
- Kadimastem grew their employee count by -9% last year.
Kadimastem's People
| Name | Title | Email/Phone |
|---|
Kadimastem Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Kadimastem?
Kadimastem (TASE:KDST) A clinical stage biotech company introducing a cutting-edge TECHNOLOGY PLATFORM for the Development, Manufacturing, and Bio-Banking of functional human cells, providing OFF-THE-SHELF TREATMENT for multiple indications.
keywords:N/A
N/A
Total Funding
49
Number of Employees
$7.6M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kadimastem News
2022-03-22 - Kadimastem Receives Grant for a Total Budget of NIS 10 Million ($3.1 million) from the Israeli Innovation Authority
Kadimastem is a clinical stage cell therapy company, developing and manufacturing "off-the-shelf", allogeneic, proprietary cell products based...
Other Companies in Nes Ziona
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11M | 50 | -6% | N/A |